查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829645

2025年全球先天性心臟疾病设备市场报告

Congenital Heart Defect Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，先天性心臟疾病器材市场呈现强劲成长势头，市场规模从2024年的29.1亿美元成长至2025年的31.1亿美元，复合年增长率达6.8%。预测期内的成长归因于医疗保健意识宣传活动的不断提升、心臟缺陷筛检计画的不断推进、医疗设备法规的不断改进、先天性心臟病盛行率的不断上升以及器官衰竭风险的不断上升。

预计未来几年先天性心臟疾病器材市场规模将强劲成长，到2029年将达到41.4亿美元，复合年增长率为7.4%。预测期内的增长可归因于临床试验的增加、老年人口的快速增长、先天性心臟疾病率的上升、政府支持和资金的增加以及专科医疗中心的增加。预测期内的主要趋势包括技术进步、数位健康科技、个人化医疗、3D列印技术和穿戴式装置。

先天性心臟疾病装置是专门设计用于治疗和管理先天性心臟缺陷的医疗器材或植入。这些装置用于诊断、治疗和支持先天性心臟疾病患者的心臟功能，旨在恢復正常血流并改善心臟功能。

先天性心臟疾病装置的主要类型包括导管、心律调节器（单腔、双腔、双心室和无线）、植入式心臟整流去颤器、双心室装置和植入式心电图记录器。导管是插入体内的细而柔韧的管子，用于诊断、治疗和监测等各种目的。这些装置用于治疗各种类型的先天性缺陷，例如室间隔缺损、房室间隔缺损、三尖瓣闭锁和开放性动脉导管。它们广泛应用于医院、专科诊所、学术研究机构和其他医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，心臟疾病系列提供先天性心臟疾病器材市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的先天性心臟疾病心臟疾病细分市场、市场趋势和机会，以及您在先天性心臟疾病器行业取得成功所需的数据。本先天性心臟疾病器械市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

未来五年7.4%的成长率预测，较我们先前对该市场的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，导致儿科封堵器和可生物降解的鼻中隔修补片的供应链中断，这些产品主要来自法国和瑞典等主要地区，从而可能导致儿科心臟介入治疗的延误和先天性疾病手术费用的增加。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

预计先天性心臟疾病器械市场的成长将受到微创手术的推动。这些手术涉及使用专门的工具和技术透过小切口或自然身体孔口进行手术，以最大限度地减少创伤并改善恢復。推动微创手术兴起的因素包括技术进步、患者对微创治疗方法的偏好、手术技术的改进以及减少恢復时间和併发症的好处。先天性心臟疾病器械在这些手术中发挥关键作用，透过更小的切口和基于导管的方法来实现心臟异常的诊断、治疗和管理。例如，根据美国整形外科医师协会 (ASPS) 的数据，2022 年美国进行了 23,672,269 例微创美容手术，比前一年增加了 7%。微创手术的增加反过来又推动了先天性心臟疾病器械市场的发展。

先天性心臟疾病器械市场包括室间隔阻塞设备、心臟瓣膜、开放性动脉导管(PDA) 器械和生物假体器械的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球先天性心臟疾病设备：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球先天性心臟疾病设备市场：成长率分析
  • 全球先天性心臟疾病设备市场表现：规模与成长，2019-2024
  • 全球先天性心臟疾病设备市场预测：规模与成长，2024-2029，2034
  • 全球先天性心臟疾病设备：总目标市场（TAM）

第六章 市场细分

  • 全球先天性心臟疾病设备市场（按设备类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 导管
  • 起搏器
  • 单室调节器
  • 双腔起搏器
  • 双心室节律器
  • 无导线起搏器
  • 置入式除颤器
  • 双心室装置
  • 植入式心电图循环记录仪
  • 其他设备类型
  • 全球先天性心臟疾病设备市场（按缺陷类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 心房中膈缺损症
  • 室间隔缺损
  • 房室间隔缺损
  • 三尖瓣闭锁
  • 动脉干
  • 其他缺陷类型
  • 全球先天性心臟疾病设备市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所
  • 学术研究机构
  • 其他最终用户
  • 全球先天性心臟疾病设备市场：按导管类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 球囊导管
  • 诊断导管
  • 引导管
  • 全球先天性心臟疾病设备市场：按起搏器类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 单室调节器
  • 双腔起搏器
  • 双心室节律器
  • 无导线起搏器
  • 全球先天性心臟疾病设备市场：置入式除颤器市场（按类型）、业绩及预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔ICD
  • 双腔ICD
  • 皮下植入式心臟復律去颤器
  • 全球先天性心臟疾病设备市场：双心室设备细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • Crt-P（心臟再同步治疗起搏器）
  • Crt-D（心臟再同步治疗去心房颤动）
  • 全球先天性心臟疾病设备市场：细分：植入式心电图环路记录器（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 传统嵌入式循环录音机
  • 皮下植入式循环记录仪
  • 全球先天性心臟疾病设备市场：依其他设备类型细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 经导管心臟瓣膜
  • 心室辅助装置（VADS）

第七章 区域和国家分析

  • 全球先天性心臟疾病设备市场（按地区、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 全球先天性心臟疾病设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 先天性心臟疾病设备市场：竞争格局
  • 先天性心臟疾病设备市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Medtronic plc.
  • Philips Healthcare
  • Boston Scientific Corporation
  • WL Gore & Associates Inc.
  • Masimo Corporation
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • MicroPort Scientific Corporation
  • Stereotaxis Inc.
  • Berlin Heart GmbH
  • Ventracor Limited
  • Syncardia Systems LLC
  • On-X Life Technologies Inc.
  • Occlutech Holding AG
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Response Biomedical Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年先天性心臟疾病器材：提供新机会的国家
  • 2029年先天性心臟疾病设备市场：细分市场带来新机会
  • 2029年先天性心臟疾病设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29862u

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the Congenital heart defect devices industry. This Congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.91 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to growth in healthcare awareness campaigns, increasing number of heart defect screening programs, growth in medical device regulations, increasing prevalence of congenital heart defect, and increase in the risk of organ failure.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.14 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing clinical trials, a surge in the geriatric population, an increasing prevalence of congenital heart defects, rising government support and funding, and an increasing number of specialized medical centers. Major trends in the forecast period include technological advancements, digital health technologies, personalized medicine, 3D printing technology, and wearable devices.

The forecast of 7.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for pediatric-sized occluders and biodegradable septal repair patches, sourced from key regions such as France and Sweden, which could lead to delayed pediatric cardiac interventions and increased surgical expenses for congenital conditions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, according to the American Society of Plastic Surgeons (ASPS), 23,672,269 cosmetic minimally invasive procedures were performed in the United States in 2022, marking a 7% increase from previous years. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Major players in the congenital heart defect (CHD) devices market are increasingly forming strategic partnerships to develop innovative solutions. These partnerships help companies in the CHD devices sector by combining resources and expertise, enhancing research and development efforts, expanding market reach, and accelerating the commercialization process. Such collaborations foster innovation and contribute to industry growth. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, entered into a partnership with HeartX, an India-based MedTech firm, to improve patient care in the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its presence in the CHD market by incorporating HeartX's cutting-edge solutions, such as the JOVE VB Stent. This alliance enables SMT to provide advanced CHD devices that improve treatment effectiveness, simplify procedures, and enhance patient outcomes.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Pfizer Inc., Johnson & Johnson, AstraZeneca plc., Abbott Laboratories, GlaxoSmithKline plc., Medtronic plc., Philips Healthcare, Boston Scientific Corporation, W. L. Gore & Associates Inc., Masimo Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Stereotaxis Inc., Berlin Heart GmbH, Ventracor Limited, Syncardia Systems LLC, On-X Life Technologies Inc., Occlutech Holding AG, Sahajanand Medical Technologies Pvt. Ltd., Response Biomedical Corporation, Xeltis AG, Procyrion Inc., Heartstitch Inc., Cardia Inc., OSYPKA Medical GmbH

North America was the largest region in the congenital heart defect devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Catheters; Pacemakers; Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers; Implantable Cardioverter Defibrillators; Biventricular Devices; Implanted Cardiac Loop Recorders; Other Device Types
  • 2) By Defect Type: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect; Tricuspid Atresia; Truncus Arteriosus; Other Defect Types
  • 3) By End user: Hospitals; Specialty Clinics; Academic And Research Institute; Other End Users
  • Subsegments:
  • 1) By Catheters: Balloon Catheters; Diagnostic Catheters; Guiding Catheters
  • 2) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers
  • 3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds; Dual-Chamber Icds; Subcutaneous Icds
  • 4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers); Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders; Subcutaneous Implantable Loop Recorders
  • 6) By Other Device Types: Transcatheter Heart Valves; Ventricular Assist Devices (VADS)
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AstraZeneca plc.; Abbott Laboratories; GlaxoSmithKline plc.; Medtronic plc.; Philips Healthcare; Boston Scientific Corporation; W. L. Gore & Associates Inc.; Masimo Corporation; Lepu Medical Technology (Beijing) Co. Ltd.; MicroPort Scientific Corporation; Stereotaxis Inc.; Berlin Heart GmbH; Ventracor Limited; Syncardia Systems LLC; On-X Life Technologies Inc.; Occlutech Holding AG; Sahajanand Medical Technologies Pvt. Ltd.; Response Biomedical Corporation; Xeltis AG; Procyrion Inc.; Heartstitch Inc.; Cardia Inc.; OSYPKA Medical GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congenital Heart Defect Devices Market Characteristics

3. Congenital Heart Defect Devices Market Trends And Strategies

4. Congenital Heart Defect Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Congenital Heart Defect Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Congenital Heart Defect Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Congenital Heart Defect Devices Market Growth Rate Analysis
  • 5.4. Global Congenital Heart Defect Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Congenital Heart Defect Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Congenital Heart Defect Devices Total Addressable Market (TAM)

6. Congenital Heart Defect Devices Market Segmentation

  • 6.1. Global Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheters
  • Pacemakers
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers
  • Leadless Pacemakers
  • Implantable Cardioverter Defibrillators
  • Biventricular Devices
  • Implanted Cardiac Loop Recorders
  • Other Device Types
  • 6.2. Global Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect
  • Ventricular Septal Defect
  • Atrioventricular Septal Defect
  • Tricuspid Atresia
  • Truncus Arteriosus
  • Other Defect Types
  • 6.3. Global Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Academic And Research Institute
  • Other End Users
  • 6.4. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Catheters
  • Diagnostic Catheters
  • Guiding Catheters
  • 6.5. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers
  • Leadless Pacemakers
  • 6.6. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Icds
  • Dual-Chamber Icds
  • Subcutaneous Icds
  • 6.7. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crt-P (Cardiac Resynchronization Therapy Pacemakers)
  • Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 6.8. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implanted Cardiac Loop Recorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Implantable Loop Recorders
  • Subcutaneous Implantable Loop Recorders
  • 6.9. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Ventricular Assist Devices (VADS)

7. Congenital Heart Defect Devices Market Regional And Country Analysis

  • 7.1. Global Congenital Heart Defect Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Congenital Heart Defect Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congenital Heart Defect Devices Market

  • 8.1. Asia-Pacific Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congenital Heart Defect Devices Market

  • 9.1. China Congenital Heart Defect Devices Market Overview
  • 9.2. China Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congenital Heart Defect Devices Market

  • 10.1. India Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congenital Heart Defect Devices Market

  • 11.1. Japan Congenital Heart Defect Devices Market Overview
  • 11.2. Japan Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congenital Heart Defect Devices Market

  • 12.1. Australia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congenital Heart Defect Devices Market

  • 13.1. Indonesia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congenital Heart Defect Devices Market

  • 14.1. South Korea Congenital Heart Defect Devices Market Overview
  • 14.2. South Korea Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congenital Heart Defect Devices Market

  • 15.1. Western Europe Congenital Heart Defect Devices Market Overview
  • 15.2. Western Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congenital Heart Defect Devices Market

  • 16.1. UK Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congenital Heart Defect Devices Market

  • 17.1. Germany Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congenital Heart Defect Devices Market

  • 18.1. France Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congenital Heart Defect Devices Market

  • 19.1. Italy Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congenital Heart Defect Devices Market

  • 20.1. Spain Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congenital Heart Defect Devices Market

  • 21.1. Eastern Europe Congenital Heart Defect Devices Market Overview
  • 21.2. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congenital Heart Defect Devices Market

  • 22.1. Russia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congenital Heart Defect Devices Market

  • 23.1. North America Congenital Heart Defect Devices Market Overview
  • 23.2. North America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congenital Heart Defect Devices Market

  • 24.1. USA Congenital Heart Defect Devices Market Overview
  • 24.2. USA Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congenital Heart Defect Devices Market

  • 25.1. Canada Congenital Heart Defect Devices Market Overview
  • 25.2. Canada Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congenital Heart Defect Devices Market

  • 26.1. South America Congenital Heart Defect Devices Market Overview
  • 26.2. South America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congenital Heart Defect Devices Market

  • 27.1. Brazil Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congenital Heart Defect Devices Market

  • 28.1. Middle East Congenital Heart Defect Devices Market Overview
  • 28.2. Middle East Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congenital Heart Defect Devices Market

  • 29.1. Africa Congenital Heart Defect Devices Market Overview
  • 29.2. Africa Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

  • 30.1. Congenital Heart Defect Devices Market Competitive Landscape
  • 30.2. Congenital Heart Defect Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

31. Congenital Heart Defect Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc.
  • 31.2. Philips Healthcare
  • 31.3. Boston Scientific Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Masimo Corporation
  • 31.6. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Stereotaxis Inc.
  • 31.9. Berlin Heart GmbH
  • 31.10. Ventracor Limited
  • 31.11. Syncardia Systems LLC
  • 31.12. On-X Life Technologies Inc.
  • 31.13. Occlutech Holding AG
  • 31.14. Sahajanand Medical Technologies Pvt. Ltd.
  • 31.15. Response Biomedical Corporation

32. Global Congenital Heart Defect Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

34. Recent Developments In The Congenital Heart Defect Devices Market

35. Congenital Heart Defect Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Congenital Heart Defect Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Congenital Heart Defect Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Congenital Heart Defect Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer